Assessment of disease severity and activity in inflammatory bowel disease.
about
Assessing health-related quality of life in patients with inflammatory bowel disease, in Crete, GreeceHow accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?Medical options for treating Crohn's disease in adults: focus on antitumor necrosis factor-alpha chimeric monoclonal antibody.Increased leucocyte adhesiveness/aggregation is a most useful indicator of disease activity in patients with inflammatory bowel disease.Changes of blood flow volume in the superior mesenteric artery and brachial artery with abdominal thermal stimulation.Evaluation of new therapies for inflammatory bowel disease.Assessment of Crohn's disease activity by doppler ultrasound of superior mesenteric artery and mural arteries in thickened bowel wall: cross-sectional studyDoes analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?Evaluation of the effects of acupuncture on blood flow in humans with ultrasound color Doppler imaging.Resistance index in mural arteries of thickened bowel wall: predictive value for Crohn disease activity assessment in pediatric patients.The inflammatory bowel disease questionnaire: a valid and reliable measure in ulcerative colitis patients in the North East of England.Urinary neopterin is a valuable tool in monitoring Crohn's disease activity.Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.Quality-of-life factors in adolescent inflammatory bowel disease.Removal of IgG from normal plasma and plasma from untreated patients with active Crohn's disease--effect on levels of contact factors.
P2860
Q24802163-86FE5EBA-BDFA-479D-AB88-8D41AE27FBE9Q28251305-90A11265-1141-42B7-A37E-29DB5200C11AQ33747158-5B7E9F8C-84B7-4949-975C-A5BEC838EF74Q34408601-6DF28035-D8BE-42CC-AEA0-6DEB8D325799Q34983767-E7DC5CDC-AE94-4DA2-8136-14902E9342E7Q35216827-31CE65F0-75EF-4CBB-9EDB-F95C7437A74FQ36405347-4E46EFC8-75D8-4574-A43E-417FEEBB2CD6Q41705365-C6AA0AD6-AC9D-4D2B-A90A-1A1438839736Q41904953-D4598EFF-31B4-46A5-96CE-BA798CC70AD4Q43738567-260FD045-3ED7-4B6A-ADD3-09EE3197B11AQ44918162-73C22B5B-3441-4E6C-90CC-5E5BF052B440Q46561227-BDF2E0F8-D44A-4FA0-AF2E-B67C33F16086Q47821295-797A632B-929A-4A09-B90E-EB57AAA221A8Q53579937-AC22A1FB-22B4-4535-B7D4-69C8192CFC26Q54716953-445D66C8-D4CC-4ABA-A5BB-C13C91337C23
P2860
Assessment of disease severity and activity in inflammatory bowel disease.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Assessment of disease severity and activity in inflammatory bowel disease.
@en
type
label
Assessment of disease severity and activity in inflammatory bowel disease.
@en
prefLabel
Assessment of disease severity and activity in inflammatory bowel disease.
@en
P2860
P1476
Assessment of disease severity and activity in inflammatory bowel disease
@en
P2093
J Kjeldsen
P2860
P356
10.3109/00365529309096037
P577
1993-01-01T00:00:00Z